Orphan Drugs: In Development
Cushing's syndrome-A hormonal disorder caused by an abnormally high circulating level of corticosteroid hormones, normally produced by the adrenal glands. The pituitary gland controls the activity of the adrenal gland by the release of ACTH (adrenocorticotropic hormone). Overactivity of the pituitary can lead to overproduction of ACTH, leading to an excess level of circulating corticosteroids. Tumors of the pituitary and various other tumors may also stimulate ACTH (ectopic production). Cushing's syndrome causes distinct physical changes, including a red, round "moon" face, humped upper back, impotence, swelling, weakness, fatigue, and a characteristic purplish striating of the skin. Mental changes, such as depression or paranoia, also often occur. cutaneous-Pertaining to the skin. cyclophosphamide-An anticancer drug. cystic fibrosis-A genetic disorder of the exocrine glands (such as sweat glands or kidneys) that causes abnormal mucous secretions that obstruct glands and ducts in various organs. cystinosis-Cystine, an amino acid, accumulated in internal organs, resulting in damage and cystinuria (presence of cystine in urine). Nephropathic cystinosis, also called Franconi's syndrome, is a rare kidney disorder, by which nutrients and chemicals are lost in the urine, causing stunting of growth and bone disorders. cystitis, interstitial-Chronic, painful inflammation of the bladder lining, frequently accompanied by ulcers. cytomegalovirus (CMV)-A DNA virus that can cause infection without symptoms or with mild flu-like symptoms. CMV can also cause blindness (CMV retinitis). dermatitis herpetiformis-A chronic skin disease in which clusters of tiny, red, intensely itchy blisters occur in a symmetrical pattern on various parts of the body. It is believed to be the result of an allergy to gluten, a constituent of wheat and other cereals. dysphagia-Difficulty in swallowing. dysplasia, bronchopulmonaryAbnormal growth of the cells of the lungs and air passages associated with exposure of immature lungs to high levels of oxygen. endogenous-Arising from within the body. end-stage renal disease (ESRD)-An advanced, life-threatening condition caused by chronic renal failure that has progressed over months or years. engraftment-Surgically implanted tissue. epidermolysis bullosa-A rare, inherited condition in which blisters appear on the skin after minor damage. It mainly affects young children and has a wide range of severity. epidural-Space upon or over the dura, a membrane surrounding the brain and spinal cord. esophageal varices, bleeding-Dilated, weakened veins in walls of the lower part of the esophagus, which can rupture and cause acute bleeding. exogenous-Introduced from or produced outside of the body. Fabry's disease-An inherited metabolic disorder, becoming clinically apparent in childhood and adolescence with fever, pain and small vascular tumors. It progresses to central nervous system disturbances and renal and cardiac failure in mid-life. fistulas, cutaneous-An abnormal passage from an internal organ, such as the bladder or intestine, to the body's surface (cutaneous). Gaucher's disease-Type I, the adult form of an inherited disease caused by a lack or deficiency of an enzyme (glucocerebrosidase). Primarily affects the liver, spleen and bone marrow. glycosides-A class of drugs used in heart failure. A conduction disorder is a dysfunction of the electrical pathways of the heart. Ectopic ventricular activity is electrical activity in the ventricle of the heart arising from tissue other than the normal conduction pathway. Hyperkalemia is an elevation of potassium blood levels. graft vs. host disease-In bone marrow transplantation, normal bone marrow is used to replace malignant or defective marrow. In an allogeneic transplantation, healthy marrow is taken from a donor; in an autologous transplantation, the patient's own healthy marrow is used. In graft vs. host disease, a complication of such transplants, immune system cells attack the transplant recipient's tissues. granulocyte-A type of phagocytic white blood cell, which is able to wander through the body to engulf and digest harmful organisms and debris. granulomatous disease, chronic (CGD)-A congenital defect in the killing of bacteria by white blood cells, leaving patients susceptible to severe infections. Nodular lesions, called granulomas, also result and interfere with the function of various organs. hematopoietic potentiation-Helping the body to form blood or blood cells. hemodialysis-One of two methods of dialysis, which removes waste products from the body as treatment for kidney failure. This method uses a "kidney machine" to clean the blood and a shunt (passage) to connect an artery to a vein. heparin-An anticoagulant drug. hepatic-Related to the liver. hepatitis-Inflammation of the liver with accompanying liver cell damage or death, caused most often by viral infection (e.g., types delta and B), but also by certain drugs, chemicals or poisons. Hepatitis may be either acute (of limited duration) or chronic (continuing). hepatocellular-Pertaining to the cells in the liver. HIV-Human immunodeficiency virus, the virus that causes AIDS. hyperammonemia-Elevation of ammonia in blood, characteristic of many metabolic diseases and inherited disorders. Symptoms include vomiting, agitation, slurred speech, and lethargy leading to mental retardation. It can be caused by urea cycle enzymopathy (UCE), a deficiency of one or more of the enzymes (carbamylphosphate synthetase, ornithine, transcarbamylase or arginosuccinate synthetase) necessary to convert ammonia to a waste product (urea) to be eliminated in the urine. hyperbilirubinemia-A raised blood level of bilirubin, a waste product formed from the destruction of red blood cells. Jaundice becomes apparent if the bilirubin level rises to twice the normal level. hypercalcemia-Abnormally high level of calcium in the blood that can seriously disrupt cell function, particularly in muscles and nerves. hypercholesterolemia (homozygous familial)-An inherited metabolic disorder resulting in an abnormal amount of cholesterol in the blood. It can lead to accelerated atherosclerosis and early heart attack. Dietary treatment seldom helps in these cases. hyperphosphatemia-Excessive levels of phosphates in the blood can be caused by chronic kidney insufficiency or acute kidney failure. hypertension, pulmonary-High blood pressure in the arteries supplying the lungs due to increased resistance to blood flow through the lungs. In primary pulmonary hypertension (PPH), the cause is unknown. hypocalcemia-Too little calcium in the blood. One cause is hypoparathyroidism, in which insufficient parathyroid hormone is produced. In severe cases, it causes cramplike spasms in the hands, face and feet due to the effect of low blood calcium on muscle activity. Pseudohypoparathyroidism is a condition resembling a decrease or lack of parathyroid hormone. In the pseudo form, parathyroid hormone levels are normal, yet the body expresses an inability to respond to the hormone. The disease is characterized by hypocalcemia, hyperphosphatemia, and increased neuromuscular excitability that can lead to seizures or muscle spasms and twitching. hypocitraturia-Condition characterized by a decrease of citric acid in the urine causing a pH imbalance leading to calcium kidney stones. hypotension, orthostatic-Low blood pressure causing dizziness or fainting after abruptly standing or sitting up. Symptoms disappear quickly once blood pressure returns to normal. In some cases, the cause is unknown (idiopathic). infertility, anovulatory or oligovulatory-The inability to conceive due to a woman's failure to ovulate (anovulation) 20
About this Item
- Title
- Orphan Drugs: In Development
- Author
- Pharmaceutical Research and Manufacturers of America
- Canvas
- Page 20
- Publication
- Pharmaceutical Manufacturers Association.
- 1992
- Subject terms
- reports
- Series/Folder Title
- Marketplace > Press releases, reports, and newsletters
- Item type:
- reports
Technical Details
- Collection
- Jon Cohen AIDS Research Collection
- Link to this Item
-
https://name.umdl.umich.edu/5571095.0504.010
- Link to this scan
-
https://quod.lib.umich.edu/c/cohenaids/5571095.0504.010/20
Rights and Permissions
The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.
Related Links
IIIF
- Manifest
-
https://quod.lib.umich.edu/cgi/t/text/api/manifest/cohenaids:5571095.0504.010
Cite this Item
- Full citation
-
"Orphan Drugs: In Development." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0504.010. University of Michigan Library Digital Collections. Accessed June 10, 2025.